These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 4823929)

  • 1. Acute suppression of insulin and glucose levels by synthetic somatostatin in normal human subjects.
    DeVane GW; Siler TM; Yen SS
    J Clin Endocrinol Metab; 1974 May; 38(5):913-5. PubMed ID: 4823929
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.
    Gerich JE; Lorenzi M; Schneider V; Karam JH; Rivier J; Guillemin R; Forsham PH
    N Engl J Med; 1974 Sep; 291(11):544-7. PubMed ID: 4604408
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
    Vella A; Shah P; Reed AS; Adkins AS; Basu R; Rizza RA
    Diabetologia; 2002 Oct; 45(10):1410-5. PubMed ID: 12378382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The major glucagon-like peptide-1 metabolite, GLP-1-(9-36)-amide, does not affect glucose or insulin levels in mice.
    Rolin B; Deacon CF; Carr RD; Ahrén B
    Eur J Pharmacol; 2004 Jun; 494(2-3):283-8. PubMed ID: 15212985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of somatostatin on plasma glucose and insulin responses to glucagon and tolbutamide in man.
    Gerich JE; Lorenzi M; Schneider V; Forsham PH
    J Clin Endocrinol Metab; 1974 Dec; 39(6):1057-60. PubMed ID: 4430704
    [No Abstract]   [Full Text] [Related]  

  • 6. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
    Wu MS; Ho LT
    Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
    Yen SS; Siler TM; DeVane GW
    N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
    [No Abstract]   [Full Text] [Related]  

  • 8. Route of administration as a factor in the selectivity of hormone suppression of a somatostatin analog in rats.
    Lien EL; Garsky VM
    Horm Metab Res; 1981 Dec; 13(12):675-8. PubMed ID: 6119282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of caerulein in rapid venous administration of plasmatic levels of glucagon, insulin and glucose].
    Fallucca F; Carratú R; Tamburrano G; Javicoli M; Menzinger G
    Folia Endocrinol; 1969 Dec; 22(4):524-9. PubMed ID: 5409271
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic effects of butylbiguanide during long lasting intravenous glucose infusion in normal human subjects.
    Gomez F; Felber JP
    Horm Metab Res; 1970 Mar; 2(2):72-5. PubMed ID: 5520911
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.
    Villaume C; Beck B; Kolopp M; Toussain P; Debry G
    Biomed Pharmacother; 1986; 40(2):61-4. PubMed ID: 2875745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of blood insulin and growth hormone to glucose infusion in normal, psoriatic and diabetic persons.
    Hopsu-Havu VK; Terho PE; Vanha-Perttula TP; Viljanen MK
    Acta Derm Venereol; 1973; 53(1):39-44. PubMed ID: 4120806
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of somatostatin to inhibit tolbutamide-induced insulin secretion in patients with insulinomas: a possible diagnostic tool.
    Lorenzi M; Gerich JE; Karam JH; Forsham PH
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1121-4. PubMed ID: 166088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on low insulin responders. Glucose tolerance and insulin response to intravenous and oral glucose challenges in 226 normal subjects and 25 subjects with mild or chemical diabetes.
    Efendić S; Cerasi E; Elander I; Thornqvist C; Fick G; Berglund B; Luft R
    Acta Endocrinol Suppl (Copenh); 1979; 224():5-32. PubMed ID: 285561
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of surgical trauma on plasma insulin and somatostatin in response to glucose.
    Stenberg A; Gustavsson S; Lundqvist G; Thorén L
    Acta Chir Scand; 1984; 150(2):119-22. PubMed ID: 6372345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild diabetes in young subjects. Clinical aspects and plasma insulin response pattern.
    Johansen K
    Acta Med Scand; 1973; 193(1-2):23-33. PubMed ID: 4705081
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sensibility to insulin in obese children (author's transl)].
    Levy JM; Stoll C; Thierry R; Amar U; Segura N; Fischbach M
    Sem Hop; 1980 Feb 18-25; 56(7-8):354-8. PubMed ID: 6246632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early response of plasma insulin to small doses of intravenous glucose: effect of obesity.
    Pelkonen R; Taskinen MR; Nikkilä EA
    J Clin Endocrinol Metab; 1974 Sep; 39(3):418-24. PubMed ID: 4412890
    [No Abstract]   [Full Text] [Related]  

  • 19. Early insulin response to glucose injected intravenously in patients with localized granuloma annulare.
    Blohmé G; Mobacken H; Waldenström J
    Acta Derm Venereol; 1974; 54(4):259-63. PubMed ID: 4136648
    [No Abstract]   [Full Text] [Related]  

  • 20. Somatostatin modulation of pancreatic glucagon, insulin, glucose and free fatty acids following beta-adrenergic stimulation.
    Raptis S; Escobar-Jimenez F; Rosenthal J; Ditschuneit HH; Pfeiffer EF
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1088-93. PubMed ID: 874045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.